<p>Values are expressed as mean ± SD or the least square means (95% CI). The least square means were calculated by ANCOVA adjusted for baseline FMD.</p><p>Comparison of changes in %FMD before and after treatment in each group.</p
<p>Inter-quartile ranges for each value are shown in parentheses.</p><p>*Significant changes in valu...
In a clinical controlled trial involving repeated measures of continuous outcomes such as quality of...
Comparison of baseline characteristics of patients based on HOMA-IR modifications after treatment (t...
<p>Percentage changes of vascular and metabolic parameters compared with the baseline at each time p...
<p>Percentage changes from baseline values for individuals were calculated at each follow-up point a...
<p>No significant difference was observed in FMD (A), FMTD (B), and L-FMC (C) values between the two...
<p>FA, fractional anisotropy; MDD, major depressive disorder; HC, healthy control.</p><p>***P < 0.00...
<p>Mean, SD values, Mean differences and Confidence Intervals (C.I.) at baseline, 3 months, and 6 mo...
Background and Objective: For inferring a treatment effect from the difference between a treated and...
<p>Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) ...
<p>The ACR of the MetS (-/-) group was significantly greater than that of the MetS (-/+) group in wo...
<p>Mean values and group comparisons (ANOVA adjusted for smoking and ANCOVA adjusted for baseline va...
<p>Mean values are shown for percentage changes from baseline of A) FBG, B) PBG, C) body weight and ...
<p>*p = 0.028 Overall there is a significant difference between the treatment arms.</p><p>One way AN...
<p>Comparison of the baseline characteristics of the patients with and without GC-DM treatment at on...
<p>Inter-quartile ranges for each value are shown in parentheses.</p><p>*Significant changes in valu...
In a clinical controlled trial involving repeated measures of continuous outcomes such as quality of...
Comparison of baseline characteristics of patients based on HOMA-IR modifications after treatment (t...
<p>Percentage changes of vascular and metabolic parameters compared with the baseline at each time p...
<p>Percentage changes from baseline values for individuals were calculated at each follow-up point a...
<p>No significant difference was observed in FMD (A), FMTD (B), and L-FMC (C) values between the two...
<p>FA, fractional anisotropy; MDD, major depressive disorder; HC, healthy control.</p><p>***P < 0.00...
<p>Mean, SD values, Mean differences and Confidence Intervals (C.I.) at baseline, 3 months, and 6 mo...
Background and Objective: For inferring a treatment effect from the difference between a treated and...
<p>Change in microfilarial density in the treatment groups at different follow up points: Mean (SD) ...
<p>The ACR of the MetS (-/-) group was significantly greater than that of the MetS (-/+) group in wo...
<p>Mean values and group comparisons (ANOVA adjusted for smoking and ANCOVA adjusted for baseline va...
<p>Mean values are shown for percentage changes from baseline of A) FBG, B) PBG, C) body weight and ...
<p>*p = 0.028 Overall there is a significant difference between the treatment arms.</p><p>One way AN...
<p>Comparison of the baseline characteristics of the patients with and without GC-DM treatment at on...
<p>Inter-quartile ranges for each value are shown in parentheses.</p><p>*Significant changes in valu...
In a clinical controlled trial involving repeated measures of continuous outcomes such as quality of...
Comparison of baseline characteristics of patients based on HOMA-IR modifications after treatment (t...